Alimera Sciences Revenue and Competitors
Estimated Revenue & Valuation
- Alimera Sciences's estimated annual revenue is currently $300M per year.
- Alimera Sciences's estimated revenue per employee is $677,201
- Alimera Sciences's total funding is $304.4M.
Employee Data
- Alimera Sciences has 443 Employees.
- Alimera Sciences grew their employee count by 1% last year.
Alimera Sciences's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Sr. VP | Reveal Email/Phone |
2 | VP, Thought Leader Engagement | Reveal Email/Phone |
3 | VP, Managed Markets | Reveal Email/Phone |
4 | VP, Human Capital | Reveal Email/Phone |
5 | VP Global Marketing/Head Commercial Excellence | Reveal Email/Phone |
6 | VP Sales | Reveal Email/Phone |
7 | VP, Thought Leader Engagement at Alimera Sciences | Reveal Email/Phone |
8 | VP, General Counsel | Reveal Email/Phone |
9 | VP & General Counsel | Reveal Email/Phone |
10 | Co-Founder, Chief Marketing Officer, SVP Corporate Communications and Managed Markets | Reveal Email/Phone |
Alimera Sciences Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $24.5M | 122 | 8% | N/A | N/A |
#2 | $10.7M | 53 | -17% | N/A | N/A |
#3 | $9.2M | 46 | 2% | N/A | N/A |
#4 | $24.1M | 120 | 5% | N/A | N/A |
#5 | $7.2M | 36 | -20% | N/A | N/A |
#6 | $27.7M | 138 | -30% | N/A | N/A |
#7 | $39.8M | 198 | 37% | N/A | N/A |
#8 | $0.5M | 5 | 25% | $50M | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $10.3M | 51 | 11% | N/A | N/A |
What Is Alimera Sciences?
Alimera Sciences will become a leading specialty ophthalmic pharmaceutical company by delivering intelligent products for the eye care provider and consumer. We will always consider what is right for our customers, partners, shareholders and employees in our decisions. Alimera Sciences will achieve its mission because the company is dedicated to being \"ophthalmic intelligent.\" The management team has built a reputation for decisiveness, speed to market, and integrity with over 100-plus years of collective ophthalmic experience
keywords:N/A
$304.4M
Total Funding
443
Number of Employees
$300M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Alimera Sciences News
HC Wainwright dropped their price objective on shares of Alimera Sciences from $12.00 to $10.00 and set a buy rating on the stock in a report...
Alimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews.com. Posted by admin on Apr 12th, 2022.
ATLANTA, April 06, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company whose mission...
Alimera Sciences, Inc. (NasdaqGM:ALIM) announced that it has entered into a share purchase agreement for a private placement of 1,144,945 common shares, par value $0.01 per share, at a purchase price of $8.734044 per share for gross proceeds of $10,000,000 on April 14, 2021. The transaction incl ...
Alimera grants exclusive license to Ocumension for a $10 million upfront payment and up to $89 million in additional sales-based milestone payments Ocumension makes a $10 million equity investment in Alimera ATLANTA, April 14, 2021 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ: ALIM) (Alim ...
Other Companies in Alpharetta
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $69M | 453 | 2% | N/A |
#2 | $83M | 458 | 10% | N/A |
#3 | $81.4M | 465 | 5% | N/A |
#4 | $77.4M | 476 | -10% | N/A |
#5 | $163.4M | 484 | 1% | N/A |